We spoke with Mohammad Choucair, CEO of Archer Materials (ASX:AXE), about the two paradigm-shifting technologies the company is developing, i.e. graphene-based Biochips and Quantum Computing, potentially at room temperature.
How to talk about PAST HABITS in English: USED TO, WOULD and PAST SIMPLE
English Guy Tries 4 DIFFERENT ABSINTHES REVIEW | Absinthe challenge | New Years Eve
Прикол Дебил фильм продакшен часть 2
Crazy Supercar Challenge in Public!!
JToH - Fortunately Not A Tower Speedrun
THIS IS UNIQUE! A NEW Roblox Anime RNG Game just RELEASED!
AVICE PLAYED A GREAT GAME on TIER 30 INVOKER in DOTA 2!
Twiggy - Feel Emotion 1985
Interview with Archer Materials (ASX:AXE) CTO Simon Ruffell
Weebit Nano (ASX:WBT) is on track for more commercial deals in 2024
Actinogen Medical (ASX:ACW): Interview with CEO Dr Steve Gourlay
Chimeric Therapeutics (ASX:CHM): Good prospects for licensing deals
BrainChip (ASX:BRN): Post AGM interview with CEO Sean Hehir
Interview with Dr Paul Dalgleish, Managing Director of GreenHy2 (ASX: H2G).
WhiteHawk (ASX:WHK): Many opportunities in Cyber Security for the taking
Transition Resources (Pre IPO): Interview with MD David Wilson
Intelligent Monitoring Group (ASX:IMB): Interview with Executive Director Dennison Hambling
Future Battery Minerals (ASX:FBM) interview with CEO Nick Rathjen
Black Rock Mining (ASX:BKT): Its graphite project is in a great position
Oceana Lithium (ASX:OCN) interview with CEO Caue Araujo
Xamble (ASX:XGL) interview with Chairman Bangah and director Chmiel
Weebit Nano interview: We're shooting the breeze with WBT's CEO and Chair
Dimerix (ASX:DXB) shows encouraging Phase 3 interim results! Interview with CEO Dr. Nina Webster
Brainchip (ASX:BRN): All systems go in 2024!
4DS Memory (ASX:4DS): A non-volatile memory for the fast-growing Artificial Intelligence (AI) market
Archer Materials (ASX:AXE): Interview with CEO Mohammad Choucair about AXE's paradigm-shifting Tech
Dimerix (ASX:DXB) Phase 2 interim data reading should be out soon!
Weebit Nano (ASX:WBT) looks like it may be hitting some very big milestones in 2024!
Immuron (ASX:IMC): Clinical data imminent!
Dimerix' (ASX:DXB) interim analysis imminent. Interview with CEO Dr. Nina Webster.
ASX Uranium stocks are back, baby!! Investor Webinar 20 December 2023
Dissecting the Woodside Santos merger and opportunities on NASDAQ: Investor Webinar 13 December 2023